AT
Abeona Therapeutics Inc
🇺🇸XNAS.ABEOUnited StatesHealthcare
$5.38USDdown -0.10 (-1.82%)ClosedDelayed3:08 AM
Price$5.38-0.10 (-1.82%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US00289Y2063
- CUSIP
- 00431M308
Company
- Employees
- 226
- Headquarters
- Cleveland, United States
- CEO
- Dr. Vishwas Seshadri M.B.A., Ph.D.
Market
- Shares outstanding
- 57.2M
- Market cap
- $307.65M
Highlights
- Market cap
- $307.65M
- EPS LTM
- -$1.10
- P/E LTM
- -5.37
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $25.52M+392.47%up year on year
- Net income
- -$62.89M-209.86%down year on year
- Gross margin
- 56.63%+5.99%up year on year
- Free cash flow
- -$81.53M-14.36%down year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.